Connor, Clark & Lunn Investment Management Ltd. Kindred Biosciences Inc Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
N/A
-10,351 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
N/A
-12,777 Reduced 55.24%
10,351 $71,000
Q2 2019

Aug 07, 2019
SELL
N/A
-14,921 Reduced 39.22%
23,128 $193,000
Q1 2019

May 08, 2019
SELL
N/A
-20,226 Reduced 34.71%
38,049 $349,000
Q4 2018

Feb 12, 2019
SELL
N/A
-2,300 Reduced 3.8%
58,275 $638,000
Q3 2018

Nov 13, 2018
SELL
N/A
-5,000 Reduced 7.62%
60,575 $845,000
Q2 2018

Aug 02, 2018
SELL
N/A
-10,200 Reduced 13.46%
65,575 $698,000
Q1 2018

May 14, 2018
SELL
N/A
-2,600 Reduced 3.32%
75,775 $655,000
Q4 2017

Feb 09, 2018
SELL
N/A
-2,500 Reduced 3.09%
78,375 $741,000
Q3 2017

Nov 14, 2017
BUY
N/A
2,000 Added 2.54%
80,875 $635,000
Q2 2017

Aug 14, 2017
BUY
N/A
78,875
78,875 $678,000
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email